Перейти к содержимому

The Hidden Danger of Ozempic After 60: Why Your Thigh Muscles Are Getting Weaker

Dr. Aster Senior

0:00 / 0:00

The Hidden Danger of Ozempic After 60: Why Your Thigh Muscles Are Getting Weaker

26 просмотров · 2 нед. назад
Dr. Aster Senior
44 подписчика
26 просмотров · 2 нед. назад
Geriatrician Warns: Before Taking Ozempic or Wegovy After 65, Read What Happens to Your Thigh Muscle Are you or a loved one taking Ozempic, Wegovy, or semaglutide for weight loss after 65? While the drop on the bathroom scale feels like a victory, clinical body composition studies reveal a serious hidden risk for older adults: rapid skeletal muscle loss. In this video, Dr. Aster breaks down the landmark clinical trial data showing that up to 40% of weight lost on GLP-1 medications can be lean muscle and bone mass. Learn why your quadriceps and thigh muscles are your primary defense against falls, joint pain, and loss of independence, and discover the essential 3-step protocol every senior must follow to protect their strength while on these medications. Subscribe to Dr. Aster Senior for weekly evidence-based breakdowns on healthy aging, mobility, and senior care. Timestamps: 0:00 The Deceptive Number on the Bathroom Scale 1:42 What Rushed 15-Minute Consultations Leave Out 3:15 How GLP-1 Medications Shut Down Appetite in Older Bodies 5:48 The Anabolic Resistance Trap: Why the Body Harvests Muscle 8:20 The STEP-1 Trial Data: What DEXA Scans Really Show 10:45 The Story of Harold: When the Thighs Begin to Fail 14:12 Why Your Quadriceps Are Your Engine of Longevity & Fall Defense 17:05 The Sarcopenic Rebound Trap When Injections Stop 19:30 The 3-Step Muscle-Defense Framework for Seniors 22:45 4 Critical Questions to Bring to Your Next Doctor's Appointment 25:20 The Altruistic Share & Closing Thoughts 📚 Research References: Wilding JPH, et al. (STEP-1 Study Group). Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989–1002. Sargeant JA, et al. Body composition changes with GLP-1 receptor agonists in clinical practice. Diabetes Obes Metab. 2020;22(8):1321–1331. Bauer J, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14(8):542–559. Cruz-Jentoft AJ, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. Morley JE, et al. Sarcopenia: Etiology, Clinical Consequences, Intervention, and Assessment. J Cachexia Sarcopenia Muscle. 2014;5(4):253–260. Centers for Disease Control and Prevention (CDC). Hip Fractures Among Older Adults: Morbidity and Mortality Data. cdc.gov/falls. #seniorhealth #healthyaging #ozempic #wegovy #sarcopenia #over60health #fallprevention Disclaimer: This video is for educational and informational purposes only and does not constitute individual medical advice, diagnosis, or treatment. Always consult a qualified physician or geriatric specialist before starting, discontinuing, or altering any medication or nutritional regimen.